Oligopeptides As Full-length New Delhi Metallo-β-lactamase-1 (NDM-1) Inhibitors
Overview
Affiliations
'Superbug' bacteria producing NDM-1 enzyme causing wide public concern were first detected in a patient who visited India in 2008. It's an effective approach to combining β-lactam antibiotics with NDM-1 inhibitor for treating NDM-1 producing strain infection. In our research, we designed ten oligopeptides, tested IC50 values against NDM-1 enzyme, determined the MIC values of synergistic antibacterial effect and explored the binding model. We found that the oligopeptides 2 (Cys-Phe) and 5 (Cys-Asp) respectively presented IC50 values of 113 μM and 68 μM and also displayed favorable synergistic effects of the inhibitors in combination with ertapenem against genetic engineering-host E. coli BL21 (DE3)/pET30a-NDM-1 and a clinical isolate of P. aeruginosa with blaNDM-1. Flexible docking and partial charge study suggested the interaction between oligopeptide and NDM-1. Three types of action effects, hydrogen bond, electrostatic effect and π-π interaction, contributed to the inhibitory activities.
Cheng Q, Zeng P, Chan E, Chen S Curr Pharm Des. 2022; 28(44):3538-3545.
PMID: 36177630 DOI: 10.2174/1381612828666220929154255.
β-lactam/β-lactamase inhibitor combinations: an update.
Tehrani K, Martin N Medchemcomm. 2018; 9(9):1439-1456.
PMID: 30288219 PMC: 6151480. DOI: 10.1039/c8md00342d.